Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > 400$ can manipulate closing price..

<< Previous

Bullboard Posts

Next >>

Comment by sweenbyon Oct 07, 2010 7:05pm

225 Views

Post# 17542832

RE: RE: 400$ can manipulate closing price..

Most Recent Trades
Time	Price	Change	#Shares	Buyer	Seller
15:43:36	0.44	0.02	400	89 Raymond James	7 TD Sec
15:43:36	0.44	0.02	500	80 National Bank	7 TD Sec
15:29:57	0.49	0.07	1,500	79 CIBC	7 TD Sec
15:29:57	0.485	0.065	500	79 CIBC	1 Anonymous
15:20:35	0.425	0.07	300	89 Raymond James	85 Scotia
15:19:34	0.49	0.07	5,000	80 National Bank	80 National Bank
15:19:34	0.485	0.065	500	80 National Bank	89 Raymond James
15:17:02	0.485	0.065	5,000	80 National Bank	80 National Bank
15:16:57	0.47	0.05	500	7 TD Sec	89 Raymond James
15:16:47	0.47	0.05	400	89 Raymond James	7 TD Sec